News

Case Study – What makes a successful FSP relationship?

Provision of vendor oversight for biostatistics deliverables for a midsize pharmaceutical company.

This case study by Biostatistics Director Emma Jones discusses the provision of vendor oversight for biostatistics deliverables for a midsize pharmaceutical company.

Please download this case study to read more.

 

Veramed Resources, Case Study: Provision of vendor oversight for biostatistics deliverables for a midsize pharmaceutical company

Download

2.31 MB

Case Study – Providing expert input into FDA submissions

 

In this case study Jean Brooks, Biostatistics Director, shares Veramed’s experience relating to the provision of support for FDA submissions. She describes the challenges that are often faced when submitting to the FDA and provides an overview about how Veramed has mitigated these challenges to lead to a successful outcome.

Please download this case study to read more…

 

Veramed Resources, Case Study: Providing expert input into FDA submissions

Download

2.31 MB

Case Study – Working as a Functional Service Provider (FSP)

In this case Study Katherine Hutchinson, Operations Director, outlines how Veramed works as a Functional Service Provider (FSP) with clients. She discusses the challenge of outsourcing programming and statistical tasks to an external provider and gives an insight into how we have worked collaboratively to overcome them.

Please download this case study to read more

 

Veramed Resources, Case Study: Working as a Functional Service Provider (FSP)

Download

2.31 MB

Provision of vendor oversight for biostatistics deliverables for a midsize pharmaceutical company

This case study by Biostatistics Director Emma Jones discusses; Provision of vendor oversight for biostatistics deliverables for a midsize pharmaceutical company.

Emma is responsible for enabling the Veramed Biostatistics team to achieve the highest levels of quality from consultancy to reporting. Emma has a wealth of experience in vendor oversight, statistical consultancy and of clinical statistical analysis gained from a variety of leading global pharmaceutical companies. She has knowledge in both technical and non-technical aspects of study design and statistical analysis across clinical studies from Phase I-III and multiple therapeutic areas, including oncology, respiratory and immunology.

 

Veramed Resources, Case Study: Provision of vendor oversight for biostatistics deliverables for a midsize pharmaceutical company

Download

2.31 MB

“Rescuing” studies

“Rescuing” Clinical Trials: From poor delivery to high performance

No client goes into a clinical trial with the expectation that their CRO of choice is going to let them down at a critical point, and that they may have to re-examine elements of the study or – in the worst case scenario – start again.

But with so much penetration into the clinical process by CROs across the board (70 per cent of studies by 2020 according to some) it’s almost certain to happen at some point. Learn about the warning signs, and how to move forward with your study.

Rescue Study

Download

477.07 KB